Product Information
KAITLIB FE 0.8-0.025 MG CHEW TB is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.2570 per EA under NDC 68180090373. Its NADAC has been published 276 times since May 12, 2021.
FDA first approved this application on Dec 17, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180090373
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA203448FDA Approved
12/17/2015
TE Code
AB
On Market Since
2/7/2021
Price Statistics
The NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has been published 276 times since May 12, 2021, and over the history we have for it it has declined 44.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2570 per EA |
|---|---|
| All-time high | $2.6953 (Oct 13, 2021) |
| All-time low | $0.9745 (Feb 21, 2024) |
| 52-week high | $1.8790 |
| 52-week low | $1.2570 |
| Median price | $1.7313 |
| Average price | $1.6688 |
| Largest weekly change | +54.1% (Sep 22, 2021) |
| Weeks tracked | 276 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KAITLIB FE 0.8-0.025 MG CHEW TB?
The current National Average Drug Acquisition Cost (NADAC) for KAITLIB FE 0.8-0.025 MG CHEW TB, manufactured by Lupin Pharmaceuticals Inc., is $1.2570 per EA (NDC 68180090373), effective Aug 19, 2026.
How has the price of KAITLIB FE 0.8-0.025 MG CHEW TB changed over time?
Over the history we have for it, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has declined 44.1%. It has been tracked across 276 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for KAITLIB FE 0.8-0.025 MG CHEW TB?
Since May 12, 2021, the NADAC for KAITLIB FE 0.8-0.025 MG CHEW TB has ranged from a low of $0.9745 (Feb 21, 2024) to a high of $2.6953 (Oct 13, 2021), with a median of $1.7313 per EA.
Are there cheaper alternatives to KAITLIB FE 0.8-0.025 MG CHEW TB?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALYACEN 1-35 28 TABLET, is $0.2116 per EA — about 83% below KAITLIB FE 0.8-0.025 MG CHEW TB.
Who manufactures KAITLIB FE 0.8-0.025 MG CHEW TB?
KAITLIB FE 0.8-0.025 MG CHEW TB (NDC 68180090373) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.